High Court grants Novo Nordisk dynamic blocking order against six UK internet service providers to combat counterfeit Ozempic and Wegovy websites

The Intellectual Property List of the Chancery Division has granted Novo Nordisk a 'dynamic blocking' order against six major UK internet service providers — BT, EE, Plusnet, Sky, TalkTalk, and Virgin Media — enabling the pharmaceutical company to designate counterfeit medicinal product websites for blocking without returning to court each time a new site is identified. Mr Justice Adam Johnson delivered the judgment on 23 June 2026 in *Novo Nordisk A/S and Anor v British Telecommunications Plc and Ors* [2026] EWHC 1535 (Ch), varying an existing order made by Mellor J in October 2025. That original order required the six ISPs (internet service providers) to block websites selling counterfeit and unlicensed versions of Novo Nordisk's semaglutide products Ozempic and Wegovy — the widely prescribed GLP-1 receptor agonist weight-loss and diabetes drugs that have generated significant counterfeiting activity. The dynamic mechanism is notable because it shifts the enforcement trigger from a court-by-court application to a streamlined designation process controlled by Novo Nordisk. Mr Justice Adam Johnson acknowledged initial scepticism about the mechanism's propriety, particularly where certain criteria might not engage Novo Nordisk's private intellectual property rights directly, leaving regulatory and criminal wrongdoing as the basis for the order. The judgment is a significant development in the use of dynamic blocking orders as an intellectual property and consumer safety enforcement tool in English courts.